CLINICAL OBSERVATION FROM THE TREATMENT OF ICOTINIB FOR 196 CASES WITH ADVANCED NON-SMALL CELL LUNG CANCER

被引:0
|
作者
Gu, Qin A. [1 ]
Han, Hui B. [1 ]
Jiang, Yan L. [1 ]
Wang, Min H. [1 ]
Shi, Lei C. [1 ]
Xiong, Wen L. [1 ]
Zhao, Zhuo Y. [1 ]
Chu, Qing T. [1 ]
Pei, Jun [1 ]
机构
[1] Jiaotong Uniyers, Shanghai Chest Hosp, Shanghai, Peoples R China
关键词
ADVANCED NSCLC; EGFR-TKI; Icotinib;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.11-012
引用
收藏
页码:S598 / S598
页数:1
相关论文
共 50 条
  • [21] Treating advanced non-small-cell lung cancer in Chinese patients: focus on icotinib
    Liang, Jun-Li
    Ren, Xiao-Cang
    Lin, Qiang
    ONCOTARGETS AND THERAPY, 2014, 7 : 761 - 769
  • [22] Icotinib for Control of Leptomeningeal Carcinomatosis in Non-Small Cell Lung Cancer with Sensitive EGFR Mutations
    Fan, Yun
    Gong, Lei
    Huang, Zhiyu
    Miao, Lulu
    Xu, Yanjun
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S648 - S648
  • [23] Survival Analysis of Icotinib for Brain Metastases in EGFR Mutated Non-Small Cell Lung Cancer
    Zhu, Y.
    Xu, C.
    Wang, W.
    Wu, L.
    Chen, H.
    Li, X.
    Xu, C.
    Zhuang, W.
    Du, K.
    Fang, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1077 - S1077
  • [24] Dual Loading of Nanoparticles with Doxorubicin and Icotinib for the Synergistic Suppression of Non-Small Cell Lung Cancer
    Li, Ke
    Zhan, Wenhua
    Jia, Min
    Zhao, Yufeng
    Liu, Yingguang
    Jha, Rajiv Kumar
    Zhou, Liansuo
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (03): : 390 - 402
  • [25] Efficacy, safety and prognostic factors analysis of first-line icotinib treatment in advanced non-small cell lung cancer patients with mutated EGFR
    Huang, Aimi
    Shen, Qing
    Yu, Xiaolu
    Wang, Huimin
    Shi, Chunlei
    Han, Baohui
    Gu, Aiqin
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 600 - 608
  • [26] Integrating Osimertinib in Clinical Practice for Non-Small Cell Lung Cancer Treatment
    Rajappa, Senthil
    Krishna, M. Vamshi
    Narayanan, Prasad
    ADVANCES IN THERAPY, 2019, 36 (06) : 1279 - 1290
  • [27] ACTIVE IMMUNOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER
    Neninger, Elia
    Camilo Rodriguez, Pedro
    Crombet, Tania
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S194 - S194
  • [28] Efficacy of early combination of local radiotherapy and GM-CSF for advanced non-small cell lung cancer treated with icotinib
    Qiu, Ye
    He, Xinyun
    Li, Zepei
    Jiang, Yulan
    Jia, Yuming
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (03) : 791 - 797
  • [29] Efficacy of early combination of local radiotherapy and GM-CSF for advanced non-small cell lung cancer treated with icotinib
    Ye Qiu
    Xinyun He
    Zepei Li
    Yulan Jiang
    Yuming Jia
    Irish Journal of Medical Science (1971 -), 2020, 189 : 791 - 797
  • [30] Anti-Resistant Strategies: Icotinib Derivatives as Promising Non-Small Cell Lung Cancer Therapeutics
    Zhao, Zhiwei
    Du, Yu
    Chen, Xiaojie
    CURRENT CANCER DRUG TARGETS, 2025, 25 (05) : 483 - 495